5-13886135-CAAAAAAAAAA-CAAAAAA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_001369.3(DNAH5):​c.2578-10_2578-7delTTTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0236 in 1,316,524 control chromosomes in the GnomAD database, including 14 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0064 ( 11 hom., cov: 0)
Exomes 𝑓: 0.025 ( 3 hom. )

Consequence

DNAH5
NM_001369.3 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.52

Publications

2 publications found
Variant links:
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
DNAH5 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 5-13886135-CAAAA-C is Benign according to our data. Variant chr5-13886135-CAAAA-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 402730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00641 (794/123836) while in subpopulation AFR AF = 0.0211 (712/33796). AF 95% confidence interval is 0.0198. There are 11 homozygotes in GnomAd4. There are 398 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH5NM_001369.3 linkc.2578-10_2578-7delTTTT splice_region_variant, intron_variant Intron 17 of 78 ENST00000265104.5 NP_001360.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH5ENST00000265104.5 linkc.2578-10_2578-7delTTTT splice_region_variant, intron_variant Intron 17 of 78 1 NM_001369.3 ENSP00000265104.4
DNAH5ENST00000681290.1 linkc.2533-10_2533-7delTTTT splice_region_variant, intron_variant Intron 17 of 78 ENSP00000505288.1
ENSG00000251423ENST00000503244.2 linkn.254-10453_254-10450delAAAA intron_variant Intron 1 of 2 4
ENSG00000251423ENST00000637153.1 linkn.214-10453_214-10450delAAAA intron_variant Intron 1 of 2 5

Frequencies

GnomAD3 genomes
AF:
0.00640
AC:
793
AN:
123858
Hom.:
11
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0211
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00274
Gnomad ASJ
AF:
0.000664
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000516
Gnomad FIN
AF:
0.00284
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000374
Gnomad OTH
AF:
0.00362
GnomAD2 exomes
AF:
0.0300
AC:
1847
AN:
61536
AF XY:
0.0287
show subpopulations
Gnomad AFR exome
AF:
0.0376
Gnomad AMR exome
AF:
0.0501
Gnomad ASJ exome
AF:
0.0272
Gnomad EAS exome
AF:
0.00728
Gnomad FIN exome
AF:
0.0303
Gnomad NFE exome
AF:
0.0246
Gnomad OTH exome
AF:
0.0265
GnomAD4 exome
AF:
0.0254
AC:
30317
AN:
1192688
Hom.:
3
AF XY:
0.0250
AC XY:
14725
AN XY:
589490
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0387
AC:
1014
AN:
26208
American (AMR)
AF:
0.0389
AC:
1035
AN:
26638
Ashkenazi Jewish (ASJ)
AF:
0.0289
AC:
586
AN:
20282
East Asian (EAS)
AF:
0.00708
AC:
229
AN:
32364
South Asian (SAS)
AF:
0.0229
AC:
1465
AN:
63918
European-Finnish (FIN)
AF:
0.0259
AC:
791
AN:
30498
Middle Eastern (MID)
AF:
0.0324
AC:
112
AN:
3460
European-Non Finnish (NFE)
AF:
0.0253
AC:
23776
AN:
939654
Other (OTH)
AF:
0.0264
AC:
1309
AN:
49666
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.289
Heterozygous variant carriers
0
2360
4719
7079
9438
11798
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
940
1880
2820
3760
4700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00641
AC:
794
AN:
123836
Hom.:
11
Cov.:
0
AF XY:
0.00678
AC XY:
398
AN XY:
58696
show subpopulations
African (AFR)
AF:
0.0211
AC:
712
AN:
33796
American (AMR)
AF:
0.00274
AC:
33
AN:
12048
Ashkenazi Jewish (ASJ)
AF:
0.000664
AC:
2
AN:
3012
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3584
South Asian (SAS)
AF:
0.000519
AC:
2
AN:
3852
European-Finnish (FIN)
AF:
0.00284
AC:
17
AN:
5982
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
236
European-Non Finnish (NFE)
AF:
0.000374
AC:
22
AN:
58852
Other (OTH)
AF:
0.00361
AC:
6
AN:
1662
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
30
60
89
119
149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0119
Hom.:
15

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 02, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 24, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency, No homozygotes in ExAC, but on the low side of coverage. Gene is associated with PCD.

Primary ciliary dyskinesia Benign:1
Sep 27, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.5
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71600031; hg19: chr5-13886244; API